News About: Pharm. Industry
Chongkundang forecasted 300.4 billion won of sales in 2006.
Chongkundang took a new year ceremony at Cheonan plant on Jan. 2, and announced 2006 sales forecast at 300,400 million won.
President Lee Jang-han said "We deeply appreciated to all company staffs and executive me...
Yuhan to commit "Yuhan 80 years, new leap-up and history creation"
Yuhan took the 84 fiscal year business inauguration ceremony at the auditorium on Jan. 2 and made a commitment of new start under the title of "Yuhan 80 years, new leap-up and history creation"
President Cha Joong-...
Green Cross to construct new plant and launch new management innovation.Green Cross took a new year business inauguration ceremony at the 7th floor of Mokam building at Suji Yongin on Jan. 2 in attendance of 500 members including subsidiaries, GCJBP...
|
Dong-A estimated 605.5 BW of sales and 50 BW of ordinary incomes in 2005.
Dong-A tentatively reported the sales and ordinary incomes of 2005 at 605 billion won and 50 billion won respectively largely due to the remarkable growth of Styrene and Nicetil.
The company announced to launch the...
Boryung to declare annual 30% growth in the new year ceremony.Boryung celebrated a new year at the 17th floor of Boryung building on Jan. 2, declaring to achieve the 2006 sales target under the slogan of "Growth maximization through a limi...
|
Hanmi IT's sales administration software to file patent registration.
Hanmi IT announced that the sales administration system called 3Call filed for the patent registration in Korea.
The 3Call system is a sales activity administration for the pharmaceutical salesmen via on or off-com...
KFDA approved clinical studies for Sewon Cellontech's Ostem.
Sewon Cellontech announced on Dec. 28 that the KFDA approved the clinical study for Ostem, a cell therapy by differentiating adult stem cells into osteoblasts to treat bone necrotic disease.
The clinical study may ...
Pharmaceutical industry raised R&D investment to 5%.
The Korean pharmaceutical industry has raised an ongoing investment rate for the R&D-to-sales according to the KPMA report.
The report indicated that the total sales of 37 listed drug companies in 2004 amounted to ...
Chongkundang distributes Avelox under sole agreement with Bayer.
Chonkundang made an exclusive distribution agreement for Avelox, a quinolone antibiotic, with Bayer Korea to sell exclusively in Korea starting from Jan. next year, which may give a strong power to Chonkundang's antib...
Kolmar Korea to register patent of new nano natural compounds.
Kolmar Korea has completed the patent registration of nano size of phospholipid liposome cosmetics and its manufacturing process (No. 0530880)
The patented technology of new natural nano compound and its manufactur...
